The role and significance of biomarker for plasma G-CSF in patients with primary lung cancer

Tuberculosis and Respiratory Diseases

Volumn 66, Issue 6, 2009, Pages 444-450

  Jung, Sub Song ^a   So, Young Kim ^a   Hyang, Jeong Jo ^b   Kang, Kyoo Lee ^b   Jeong, Hyun Shin ^a   Seong, Nam Shin ^a   Kim, Dong ^a   Seong, Hoon Park ^b   Young, Jin Lee ^b   Chang, Bo Ko ^c   Mi, Kung Lee ^b   Soon, Ho Choi ^b   Jong, Hoon Jeong ^a   Jung, Hyun Park ^a   Hui, Jung Kim ^a   Hak, Ryul Kim ^a   Eun, Taik Jeong ^a   Sei, Hoon Yang ^a  

^a Wonkwang University Hospital   (South Korea)

^b Wonkwang University   (South Korea)

^c Good Cell Life Inc   (South Korea)

Author keywords

Biological markers; Granulocyte colony stimulating factor; Lung neoplasms; Metastasis

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR MARKER;

ADRENAL METASTASIS; ADVANCED CANCER; AGE; AGED; ARTICLE; BONE METASTASIS; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CIGARETTE SMOKING; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PROTEIN BLOOD LEVEL;

EID: 67749095014     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2009.66.6.444     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-33S.
3. Albain KS, Crowley JJ, Livingston RB. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. Chest 1991;99: 1425-1432
4. Cooper DL. Tumor markers. In: Goldman L, Bennett JC, editors. Cecil textbook of medicine. 21st ed. Philadelphia: W. B. Saunders company; 2000. p. 1039-1042
5. Müller LC, Gasser R, Huber H, Klingler A, Salzer GM. Neuron-specific enolase (NSE) in small-cell lung cancer: longitudinal tumors marker evaluation. Lung Cancer 1992;8:29-36.
6. Akoun GM, Scarna HM, Milleron BJ, Bénichou MP, Herman DP. Serum neuron-specific enolase: a marker for disease extent and response to therapy for small- cell lung cancer. Chest 1985;87:39-43.
7. Bonomi P, Gale M, Rowland K, Taylor SG 4th, Purl S, Reddy S, et al. Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment. Int J Radiat Oncol Biol Phys 1991;20:247-252
8. Karnak D, Ulubay G, Kayacan O, Beder S, Ibis E, Oflaz G. Evaluation of Cyfra 21-1: a potential tumor marker for non-small cell lung carcinomas. Lung 2001;179: 57-65. (Pubitemid 32667451)
9. McDermott RS, Deneux L, Mosseri V, Védrenne J, Clough K, Fourquet A, et al. Circulating macrophage colony stimulating factor as a marker of tumor progression. Eur Cytokine Netw 2002;13:121-127 (Pubitemid 34535582)
10. Miyagawa K, Chiba S, Shibuya K, Piao YF, Matsuki S, Yokota J, et al. Frequent expression of receptors for granulocyte-macrophage colony-stimulating factor on human nonhematopoietic tumor cell lines. J Cell Physiol 1990;143:483-487 (Pubitemid 20201664)
11. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992;80:374-381
12. Tani K, Ozawa K, Ogura H, Shimane M, Shirafuji N, Tsuruta T, et al. Expression of granulocyte and granulocyte macrophage colony-stimulating factors by human non-hematopoietic tumor cells. Growth Factors 1990;3:325-331
13. Yee LD, Liu L. The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res 2000;20:4379-4383 (Pubitemid 32141790)
14. Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Laszewicz W, et al. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta 2007; 380:208-212
15. Usami N, Uchiyama M, Kawaguchi K, Yasuda A, Ito S, Yokoi K. Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma. J Thorac Oncol 2007;2:257-258 (Pubitemid 47181333)
16. Kobashi Y, Okimoto N, sakamoto K. Squamous cell carcinoma of the lung producing granulocyte colony- stimulating factor and resembling a malignant pleural mesothelioma. Intern Med 2004;43:111-116
17. Buccheri G, Ferrigno D. Lung tumor markers of cytokeratin origin: an overview. Lung Cancer 2001;34 Suppl 2:S65-9.
18. Body JJ, Sculier JP, Raymakers N, Paesmans M, Ravez P, Libert P, et al. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer. Cancer 1990;65:1552-1556 (Pubitemid 20106114)
19. Buccheri G, Ferrigno D. Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer. Chest 1988;93:565-570
20. Sculier JP, Body JJ, Jacobowitz D, Fruhling J. Value of CEA determination in biological fluids and tissues. Eur J Cancer Clin Oncol 1987;23:1091-1093 (Pubitemid 17112467)
21. Mino N, Iio A, Hamamoto K. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 1988;62:730-734 (Pubitemid 18186099)
22. Wieskopf B, Demangeat C, Purohit A, Stenger R, Gries P, Kreisman H, et al. Cyfra 21-1 as a biologie marker of non-small cell lung cancer: evaluation of sensitivity, specificity, and prognostic role. Chest 1995;108:163-169
23. Mroczko B, Szmitkowski M, Okulczyk B. Granulocyte- colony stimulating factor (G-CSF) and macrophage- colony stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med 2002;40:351-355 (Pubitemid 34546230)
24. Mroczko B, Szmitkowski M. Hematopoietic cytokines as tumor markers. Clin Chem Lab Med 2004;42:1347-1354
25. Asano S, Urabe A, Okabe T, Sato N, Kondo Y. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 1977;49:845-852 (Pubitemid 8093480)
26. Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 1989;73:117-122 (Pubitemid 19040964)
27. Hasegawa S, Suda T, Negi K, Hattori Y. Lung large cell carcinoma producing granulocyte-colony stimulating factor. Ann Thorac Surg 2007;83:308-310 (Pubitemid 44917855)
28. Tsuruta N, Yatsunami J, Takayama K, Nakanishi Y, Ichinose Y, Hara N. Granulocyte-macrophage-colony stimulating factor stimulates tumor invasiveness in squamous cell lung carcinoma. Cancer 1998;82:2173-2183 (Pubitemid 28240824)